Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 4/29/2025JW and Juno Forge sLVV Licensing Agreement to Advance Cell Therapy Man...
  • 4/29/2025XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...
  • 4/29/2025CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...
  • 4/29/2025Ribo Life Science Files for IPO on HKSE, Backed by CICC and Citi
  • 4/29/2025PegBio Poised for IPO on Hong Kong Stock Exchange Following Successful...
  • 4/29/20253SBio Advances Novel MUC17-Targeting Therapy SSS59 into Global Phase 1...
  • 4/29/2025Innovent Initiates Global Phase 1 Trial for ADC IBI3020
  • 4/29/2025DualityBio and AstraZeneca Unite to Investigate Novel Lung Cancer Comb...
  • 4/29/2025Qyuns Sets Up Newco for Global Rights to Its Novel Long-Acting BsAb QX...
  • 4/29/2025Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial
  • 4/26/2025Recent Executive Moves
  • 4/25/2025China's Innovative Drug Licensing Deals Soar, Big Pharma Leads the Buy...
  • 4/25/2025China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...
  • 4/25/2025Akeso's Ivonescimab Gains Second Approval in China
  • 4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma
  • 4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...
  • 4/25/2025China's Fast-Track Drug Approvals Accelerating Access to Novel Therapi...
  • 4/25/2025AstraZeneca China Announces Major Reorganization to Bolster Biopharma ...
  • 4/25/2025JIBP Aims for Hong Kong IPO amid Biopharma Market Revival
  • 4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...
  • 4/24/2025LTZ Thera Secures $40M in Oversubscribed Series A+ to Advance FIC Im...
  • 4/24/2025Merck's Gardasil Sales Plunge Amid China Market Turbulence
  • 4/24/2025Bayer Pharma Accelerates Growth in China with Breakthru Therapies and ...
  • 4/24/2025Ascletis Challenges Lilly, Novo With Promising Oral GLP-1 Data
  • 4/23/2025Global Pharma Feels 'Sense of Urgency' to De-Risk from China Amid Risi...
  • 4/23/2025China Accelerates Development of Multivalent Vaccines and Digital Immu...
  • 4/22/2025Carbogen Amcis Secures Chinese Drug Manufacturing License
  • 4/22/2025Fujifilm Capitalizes on U.S.-China Tensions with $3B Biopharma Deal
  • 4/22/2025Fosun Boosts Stake in Henlius After Failed Privatization Attempt
  • 4/22/2025China Seeks Feedback on ICH Draft Guideline M13B for Biowaivers of Add...
  • Page:22/57 Total number of articles:1697: [First][<<] [20] [21] [22] [23] [24] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group